Research

Hold Pfizer India Ltd - Kotak Securities PCG

Posted On : 2006-10-03 04:49:41( TIMEZONE : IST )

Kotak Securities has given a Hold rating on Pfizer India Ltd. The current market price of Pfizer India Ltd is Rs.900.

Source : Kotak Securities

Keywords

Warning: Undefined array key "recCount" in /var/www/vhosts/equitybulls.com/httpdocs/category.php on line 359

Warning: Undefined array key "catName" in /var/www/vhosts/equitybulls.com/httpdocs/category.php on line 369

Navin Fluorine International - Muted performance - HDFC Securities
Maintain ADD on Heidelberg Cement - Cost pass-through efforts to protect margin - HDFC Securities
Maintain BUY on Mastek - Minor misses, recovery underway - HDFC Securities
Oil and Gas - Q2FY22 Results Preview Report - HDFC Securities
Building Materials - Q2FY22 Results Preview Report - Strong recovery! - HDFC Securities
Jubilant Foodworks - Soft SSSG in the quarter but record store openings points to strong outlook ahead - YES Securities
L&T Technology Services - Overall, performance was ahead of expectations - YES Securities
Just Dial Ltd - Both revenue and EBITDA below expectation. PAT boosted by higher other income - YES Securities
Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities
GMR Infrastructure - Airports to drive value; initiate with a HOLD - ICICI Securities
ICICI Prudential Life Insurance - Business mix more balanced than ever; volume vs margin pose near-term quandary - ICICI Securities
HeidelbergCement India - Margins impacted by cost escalations - ICICI Securities
Navin Fluorine International - Revenue growth still some time away - ICICI Securities
Havells India - Strong volume led revenue growth - ICICI Securities
Q3CY21 Result Update - ACC Ltd - ICICI Direct
Q2FY22 Result Update - 5paisa Capital - ICICI Direct
Q2FY22 Result Update - Hindustan Unilever - ICICI Direct
Tata Communications - Q2FY22 First Cut - ICICI Direct
Q3CY21 Result Update - Nestle India - ICICI Direct
HeidelbergCement India - 2QFY22 Result Update - Steady Volume and Better Realizations Aid Performance - Reliance Research
Maintain BUY on UltraTech Cement - Strong demand moderates impact of cost inflation - HDFC Securities
ACC - 2QFY22 Result Update - Performance Beat Despite Elevated Input Costs - Reliance Securities
Maintain ADD on L&T Infotech - Riding the wave - HDFC Securities
Maintain REDUCE on Hindustan Unilever - Miss in volume, no respite on margin front - HDFC Securities